EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Autism spectrum disorder profiles in RASopathies : A systematic review

Edward Debbaut iD, Jean Steyaert iD, Mouna El Bakkali

Molecular Genetics & Genomic Medicine · 2024-04 · 12 (4)

DOI: 10.1002/mgg3.2428 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 05.04.2024. Verfasst von Edward Debbaut und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Noonan Syndrome, Heart Defects, Congenital, Costello Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

RASopathies are associated with an increased risk of autism spectrum disorder (ASD). For neurofibromatosis type 1 (NF1) there is ample evidence for this increased risk, while for other RASopathies this association has been studied less. No specific ASD profile has been delineated so far for RASopathies or a specific RASopathy individually.

Methods

We conducted a systematic review to investigate whether a specific RASopathy is associated with a specific ASD profile, or if RASopathies altogether have a distinct ASD profile compared to idiopathic ASD (iASD). We searched PubMed, Web of Science, and Open Grey for data about ASD features in RASopathies and potential modifiers.

Results

We included 41 articles on ASD features in NF1, Noonan syndrome (NS), Costello syndrome (CS), and cardio‐facio‐cutaneous syndrome (CFC). Individuals with NF1, NS, CS, and CFC on average have higher ASD symptomatology than healthy controls and unaffected siblings, though less than people with iASD. There is insufficient evidence for a distinct ASD phenotype in RASopathies compared to iASD or when RASopathies are compared with each other. We identified several potentially modifying factors of ASD symptoms in RASopathies.

Conclusions

Our systematic review found no convincing evidence for a specific ASD profile in RASopathies compared to iASD, or in a specific RASopathy compared to other RASopathies. However, we identified important limitations in the research literature which may also account for this result. These limitations are discussed and recommendations for future research are formulated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderNoonan SyndromeHeart Defects, CongenitalCostello SyndromeNeurofibromatosis 1HumansFailure to Thrive

Stichwörter der Autor:innen

Costello syndromeNoonan syndromeRASopathiesautism spectrum disordercardio‐facio‐cutaneous syndromedevelopmental phenotypeneurofibromatosis type 1

Autor:innen und Institutionen

  • Center for Developmental Psychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium.
  • Leuven Autism Research (LAuRes), KU Leuven, Leuven, Belgium.
  • Faculty of Medicine, KU Leuven, Leuven, Belgium.

ORCID-Profile: Edward Debbaut, Jean Steyaert

Zitieren

APA

Debbaut, E., Steyaert, J., & El Bakkali, M. (2024). Autism spectrum disorder profiles in RASopathies : A systematic review. Molecular Genetics & Genomic Medicine, 12(4). https://doi.org/10.1002/mgg3.2428

Vancouver

Debbaut E, Steyaert J, El Bakkali M. Autism spectrum disorder profiles in RASopathies : A systematic review. Molecular Genetics & Genomic Medicine. 2024;12(4). doi:10.1002/mgg3.2428

BibTeX
@article{Debbaut2024,
  author = {Debbaut, Edward and Steyaert, Jean and El Bakkali, Mouna},
  title = {Autism spectrum disorder profiles in RASopathies : A systematic review},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  volume = {12},
  number = {4},
  doi = {10.1002/mgg3.2428}
}
Kostenlos starten →